Stanley Schwartz, MD, FACP, FACE is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa.  Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago.

Transcript of our Exclusive Interview: Stanley Schwartz talks with Diabetes in Control Publisher Steve Free during the AACE 2018 convention in Boston about the changing classifications of diabetes, why we need to move beyond thinking in terms of type 1 and type 2, and the need for precision medicine in treating patients with all types of diabetes.

In this Exclusive Interview, Stanley Schwartz talks with Diabetes in Control Publisher Steve Free during the AACE 2018 convention in Boston about the changing classifications of diabetes and the need for precision medicine in treating patients with all types of diabetes.

In part 1 of this Exclusive Interview, Stanley Schwartz talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about the classification of diabetes and the learnings that have happened since first creating the various diabetes designators.

In part 2 of this Exclusive Interview, Stanley Schwartz talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about the philosophy behind using multiple drugs to more aggressively treat diabetes earlier in the life of the disease.

In part 3 of this Exclusive Interview, Stanley Schwartz talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about the effectiveness of multi-drug treatment and the time needed to help a patient to achieve their diabetes management goal.

In part 4 of this Exclusive Interview, Stanley Schwartz talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about precision medicine, which is identifying beta markers in patients in order to determine the best medications to use.

In part 5, the conclusion of this Exclusive Interview, Stanley Schwartz talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about the studies that could make a more accurate and effective set of diabetes guidelines and process of care.

In this week's Homerun Slides, we begin to take a look at how the structure of technology's use in outpatient care. Dr. Stanley Schwartz discusses how this might benefit the management of diabetes.

By Stanley S. Schwartz, MD and Mary E Herman, PhD

Despite guidelines, hypoglycemia can largely be avoided without shortchanging tight glucose control.